Formation of Monohydroxy Derivatives of Arachidonic Acid, Linoleic Acid

Total Page:16

File Type:pdf, Size:1020Kb

Formation of Monohydroxy Derivatives of Arachidonic Acid, Linoleic Acid Formation of monohydroxy derivatives of arachidonic acid, linoleic acid, and oleic acid during oxidation of low density lipoprotein by copper ions and endothelial cells Tao Wang,' Wen@ Yu, and William S. Powell* MeakinsChristie Laboratories, Respiratory Health Network of Centers of Excellence, Department of Medicine, McGill University, 3626 St. Urbain Street, Montreal, Quebec, Canada H2X 2P2; and the Endocrine Laboratory, Royal Victoria Hospital, 687 Pine Avenue West, Montreal, Quebec, Canada, H3A 1Al Abstract An important event in the formation of arachidonic acid, linoleic acid, and oleic acid during oxida- atherosclerotic lesions is the uptake of modified low density tion of low density lipoprotein by copper ions and en- lipoprotein (LDL) by macrophages via scavenger receptors. dothelial cells. J. Lipid Res. 1992. 33: 525-537. Modification of LDL, which results in its recognition by these receptors, can be initiated by peroxidation of LDL Supplementary key words lipid peroxidation unsaturated fatty lipids. The first step in this process is the formation of acids conjugated dienes thiobarbituric acid-reactive substances monohydroperoxy derivatives of fatty acids, which are sub gas chromatography-mass spectrometry sequently degraded to the corresponding monohydroxy compounds, or to a variety of secondary oxidation products. In order to understand this process more completely, we One of the pathological characteristics of have developed a mass spectrometric procedure to measure atherosclerosis is the formation of lipid-laden cells the amounts of specific hydroperoxy/hydroxy fatty acids formed by oxidation of the major unsaturated fatty acids in (foam cells) underneath the endothelium of arteries. human LDL, oleic acid, linoleic acid, and arachidonic acid. Many of these foam cells are present in the early stages Oxidation of human LDL in the presence of a relatively of the lesion and are postulated to be derived from cir- strong stimulus (20 p~ CuSO4) resulted in very large in- culating monocytes which have taken up low density creases in the amounts of the major monohydroxy deriva- lipoprotein (LDL) (1, Although normal LDL is not tives of linoleic acid (9- and 13hydroxy derivatives) and 2). arachidonic acid (5-, 8-, 9-, 11-, 12-, and 15-hydroxy deriva- well taken up by monocytes (3), LDL that has been tives) in LDL lipids in the early stages of the reaction. After 20 h, the amounts of these products declined due to sub strate depletion, but large amounts of monohydroxy deriva- tives of oleic acid (8-, lo-, and 11-hydroxy derivatives) were detected. Although thiobarbituric acid-reactive substances Abbreviations: LDL, lowdensity lipoprotein; TBARS, thiobar- clearly increased under these conditions, the changes were bituric acid-reactive substances; WHHL, Watanabe heritable hyper- not nearly so dramatic as those observed for monohydroxy lipidemic; EDTA, ethylenediamine tetraacetic acid; ETYA, 5,8,11,14 fatty acids. Oxidation of LDL in the presence of endothelial eicosatetraynoic acid; MSTFA, "ethyl-Ntrimethylsilyltrifluorcl cells, a much milder stimulus, resulted in 2.5- to Sfold in- acetamide; HPLC, high pressure liquid chromatography; ODS, oc- creases in the amounts of monohydroxy derivatives of tadecylsilyl GC,gas chromatography; MS, mass spectrometry; HETE, linoleic and arachidonic acids, as well as thiobarbituric acid- hydroxyeicosatetraenoic acid; PUFA, polyunsaturated fatty acids; h- reactive substances, with more modest increases in the 18:0, hydroxyoctadecanoic acid, h-20:0, hydroxyeicosanoic acid; 8h- amounts of hydroxylated derivatives of oleic acid. There was 18:1, 8-hydroxy-9-octadecenoic acid; 10h-18:1, 10-hydroxy-hc- little positional specificity in the oxidation of the above fatty tadecenoic acid; 11h-18:0, 1I-hydroxy-9-octadecenoic acid; 9h- 182, acids in the presence of either stimulus, suggesting that the 9-hydroxy-IO,12-octadecadienoic acid; 13h-18:1, 13-hydroxy-9,l I-oc- formation of these products proceeds primarily by lipid tadecadienoic acid; 5h-20:4, 5-hydroxy-6,8,11,14eicosatetraenoic peroxidation, rather than by catalysis by lipoxygenases. How- acid; 8h-20:4, &hydroxy-5,9,11,14-eicosatetraenoicacid; 9h-20:4, 9- ever, an important role for lipoxygenases in the initiation of hydroxy-5,7,11,14-eicosatetraenoic acid 1lh-20:4, 1 I-hydroxy- these reactions cannot be excluded. In conclusion, 5,8,12,lkicosatetraenoic acid; 12h-204, 12-hydroxy-5,8,10,14 oxidation of LDL in the presence of copper ions or en- eicosatetraenoic acid; 1531-204, 15-hydroxy-5,8,11,13-eicosate- dothelial cells results in the formation of a large number of traenoic acid. monohydroxy derivatives of oleic, linoleic, and arachidonic 'Present address: DCpartement de Pharmacplogie, FacultC de acids. The relative amounts of products formed from each MCdicine, Universitk de MontrCal, 2900, boul Edouard-Montpetit, C.P. 6128, succursale A, Montreal, QuCbec, Canada, H3C 357. of these fatty acids depends on the strength of the stimulus 'To whom correspondence and reprint requests should be ad- as well as the incubation time.-Wang, T., W-g. Yu, and W. dressed at: Meakins-Christie Laboratories, 3626 St. Urbain Street, S. Powell. Formation of monohydroxy derivatives of Montreal, Quebec, Canada, H2X 2P2. Journal of Lipid Research Volume 33, 1992 525 chemically modified by acetylation (3) or biologically MATERIALS AND METHODS modified by treatment with endothelial cells (4, 5), arterial smooth muscle cells (6), activated human Materials monocytes (7, 8), activated platelets (9-11) as well as Ham's F10 medium was purchased from Flow by extracts from human atherosclerotic lesions (12), is Laboratories, Inc. 1,1,3,3Tetramethoxypropane, avidly taken up via monocyte scavenger receptors. propyl gallate, and Diazold were obtained from The biological modification of LDL is accompanied Aldrich. Sodium chloride, potassium bromide, by increases in the amounts of thiobarbituric acid-reac- ethylenediamine tetraacetic acid (EDTA, disodium tive substances (TBARS) and other lipid peroxidation salt), ricinoleic acid (12h-18:1), and thiobarbituric products and is inhibited by superoxide dismutase (8, acid were purchased from the Sigma Chemical Com- 13), antioxidants (4), and lipoxygenase inhibitors pany. Anhydrous methanol and other solvents were (14), depending on the cell type. This suggests that from Fisher Scientific. Oleic, linoleic, and arachidonic this process is initiated by lipid peroxidation due acids were purchased from Nu-Chek Prep, Inc. either to superoxide, which is released from smooth muscle cells and monocytes, or to radicals formed Preparation of standards for quantitation of during the lipoxygenase-catalyzed oxidation of fatty monohydroxy fatty acids by mass spectrometry acids by endothelial cells. The importance of lipid Monohydroxy derivatives of oleic acid. Hydroxy deriva- peroxidation in the development of atherosclerosis is tives of oleic acid (h-18:l) were prepared by autooxida- supported by the finding that probucol, due to its an- tion of oleic acid by a procedure similar to the one tioxidant properties, prevented the formation of described in the literature for the preparation of lesions in WHHL rabbits (15-17). hydroxy derivatives of arachidonic acid (20). Oleic Lipid peroxidation is characterized by the abstrac- acid (10 mg; 99% purity) was dissolved in methanol tion of a hydrogen atom from an allylic methylene (40 ml) followed by the addition of 10 ml of 0.2 M Tris group to form an alkyl radical, followed by migration buffer containing cupric sulfate (final concentration of one of the double bonds and insertion of molecular of 100 pM). The reaction mixture was stirred for 5 h at oxygen to give a peroxyl radical. Peroxyl radicals are room temperature in the presence of hydrogen converted to hydroperoxides as a result of abstraction peroxide (0.36 mmol; 400 pl of a 30% solution) which of a hydrogen atom from another molecule of un- was added at 0, 1, and 3 h of the incubation. The reac- saturated fatty acid, initiating a chain reaction. The tion mixture was then diluted with H20 (100 ml) and position at which oxygen is inserted depends on which extracted on an ODSsilica SepPak (21). The hydro- hydrogen is abstracted. In the case of a monoun- peroxy products were reduced with sodium saturated fatty acid, oxygenation occurs at either end borohydride and purified using an open column of of the two possible allylic radicals. Therefore, four silicic acid (22). This was followed by normal-phase- positional isomers, substituted in the 8, 9, 10, and 11 high pressure liquid chromatography (NP-HPLC) positions, will be formed from oleic acid (18). In the purification on a 5 pm RoSil silicic acid column (350 x case of polyunsaturated fatty acids, each 1,4cis,ci*pen- 4.6 mm; Alltech Associates) using a mobile phase con- tadiene group will give rise to two positional isomers. sisting of isopropanol-hexane-acetic acid 0.9:99:0.1. For example, 9- and 13-hydroperoxy isomers will be 8H-18:l had a retention time of 48 min (Fig. 1). Frac- formed from linoleic acid (18),whereas 5-, 8-, 9-, 11-, tions containing either 10h-18:l (27.5-29.5 min) or 12-, and 15-hydroperoxy isomers will be formed from llh-18:l (26-27.5 min) were further purified by arachidonic acid (19). reversed-phase-high pressure liquid chromatography The objectives of the present study were to charac- (RP-HPLC) on a 5-pm Novapak octadecylsilyl silica terize the monohydroxy fatty acids formed by (ODSsilica) column (150 x 3.9 mm; Waters-Millipore) peroxidation of unsaturated fatty acids in LDL, before using a gradient between water-acetonitrile-acetic and after treatment with copper ions or endothelial acid 60:40:0.02 and water-acetonitrile-acetic acid cells. Two distinct patterns for the formation of 35:65:0.02 over 30 min followed by isocratic elution monohydroxy fatty acids in the presence of Cu2+were with the latter mobile phase. 10H-18:l and llh-18:l apparent. Products formed from oleic acid increased had retention times of 33.4 min and 30.1 min, respec- linearly with time, so that after 20 h, they were the tively.
Recommended publications
  • (12) United States Patent (10) Patent No.: US 6,692,728 B2 Weipert Et Al
    USOO6692728B2 (12) United States Patent (10) Patent No.: US 6,692,728 B2 Weipert et al. (45) Date of Patent: Feb. 17, 2004 (54) POLYESTERS BASED ON HYDROXY FATTY (52) U.S. Cl. ......................... 424/59; 424/497; 424/489; ACDS AND LOWER HYDROXY ALKYL 424/70.11; 424/78.37; 424/78.08; 514/785; ACDS AND USES THEREOF 560/171; 560/172; 560/176; 560/183; 525/400 (58) Field of Search .......................... 424/59, 497, 489, (75) Inventors: Paul David Weipert, High Point, NC 424/70.11, 78.37; 514/785; 560/172,176, (US); Bharat B. Desai, Spartanburg, 183; 525/400 SC (US) (73) Assignee: Ethox Chemicals LLC, Greenville, SC ") References Cited (US) U.S. PATENT DOCUMENTS ( c: ) Notice: Subject to any disclaimer, the term of this 5,502,116 A 3/1996 Noda ......................... 525/415 patent is extended or adjusted under 35 5,614,576 A * 3/1997 Rutherford et al. ......... 524/270 U.S.C. 154(b) by 0 days. 5,851,937 A * 12/1998 Wu et al. ................... 442/394 * cited by examiner (21) Appl. No.: 10/388,426 (22) Filed: Mar 17, 2003 Primary Examiner Sabiha Qazi 9 (74) Attorney, Agent, or Firm-Isaac A. Angres (65) Prior Publication Data (57) ABSTRACT US 2003/0175222 A1 Sep. 18, 2003 The present invention provides biodegradable polyesters Related U.S. Application Data based on lower hydroxy acids and hydroxy fatty acids. The resulting polyesters are useful as cosmetic vehicles for (62) Division of application No. 09/805,894, filed on Mar. 15, Sunscreens, skin lotions and by themselves are also useful as 2001, now Pat.
    [Show full text]
  • Assessment Report on Ricinus Communis L., Oleum Final
    2 February 2016 EMA/HMPC/572973/2014 Committee on Herbal Medicinal Products (HMPC) Assessment report on Ricinus communis L., oleum Final Based on Article 10a of Directive 2001/83/EC as amended (well-established use) Herbal substance(s) (binomial scientific name Ricinus communis L., oleum (castor oil) of the plant, including plant part) Herbal preparation Fatty oil obtained from seeds of Ricinus communis L. by cold expression Pharmaceutical forms Herbal preparation in liquid or solid dosage forms for oral use Rapporteur C. Purdel Peer-reviewer B. Kroes 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact An agency of the European Union © European Medicines Agency, 2016. Reproduction is authorised provided the source is acknowledged. Table of contents Table of contents ................................................................................................................... 2 1. Introduction ....................................................................................................................... 4 1.1. Description of the herbal substance(s), herbal preparation(s) or combinations thereof .. 4 1.2. Search and assessment methodology ..................................................................... 6 2. Data on medicinal use ........................................................................................................ 6 2.1. Information about products on the market .............................................................
    [Show full text]
  • Castor Oil Induces Laxation and Uterus Contraction Via Ricinoleic Acid Activating Prostaglandin EP3 Receptors Sorin Tunarua, Till F
    Castor oil induces laxation and uterus contraction via ricinoleic acid activating prostaglandin EP3 receptors Sorin Tunarua, Till F. Althoffa, Rolf M. Nüsingb, Martin Dienerc, and Stefan Offermannsa,d,1 aDepartment of Pharmacology, Max-Planck-Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany; dMedical Faculty, bInstitute for Clinical Pharmacology, J. W. Goethe University Frankfurt, 60590 Frankfurt, Germany; and cInstitute for Veterinary Physiology, Justus Liebig University, 35392 Giessen, Germany Edited by John H. Exton, Vanderbilt University School of Medicine, Nashville, TN, and approved April 25, 2012 (received for review January 30, 2012) Castor oil is one of the oldest drugs. When given orally, it has by the enteric nervous system or are direct effects on intestinal a laxative effect and induces labor in pregnant females. The smooth muscle remained unclear. effects of castor oil are mediated by ricinoleic acid, a hydroxylated The present study was undertaken to elucidate the molecular fatty acid released from castor oil by intestinal lipases. Despite the mechanism underlying the biological effect of castor oil-derived wide-spread use of castor oil in conventional and folk medicine, ricinoleic acid. Based on cellular signaling studies and an siRNA the molecular mechanism by which ricinoleic acid acts remains screening approach, we identified prostaglandin E2 receptors as unknown. Here we show that the EP3 prostanoid receptor is spe- targets of ricinoleic acid and show that the EP3 receptor medi- cifically activated by ricinoleic acid and that it mediates the phar- ates the effects of castor oil on the motility of the uterus and macological effects of castor oil. In mice lacking EP3 receptors, the the intestine.
    [Show full text]
  • Poster Presenter Groups
    Metabolic Engineering X- Poster Presentation Schedule Poster Group 1 (Sunday, June 15 and Monday, June 16) Poster Abstract Title Last Name First Name Number The Genetic and Metabolic Regulation of Rhamnolipids Biosynthesis in Pseudomonas Aeruginosa Reveals New Abdel- 1 Engineering Strategies for Heterologous Expression Mawgoud Ahmad M. Isotopically Nonstationary 13C Flux Analysis of 2 Isobutyraldehyde Production in Synechococcus Elongatus Adebiyi Adeola Characterization of LDH Genes for L-Lactic Acid Production in 3 Pichia Pastoris Almeida Pollyne B. A. Identification of Key Metabolite Concentrations and Enzyme Saturations Determining the Physiological States of Glucose-Fed 4 E. coli for the Production of 1,4-Butanediol Andreozzi Stefano New Advances in 13C Metabolic Flux Analysis: Complete-MFA, 5 Co-Culture MFA and Dynamic MFA Antoniewicz Maciek R. Parallel Labeling Experiments: A Novel Approach for Validating 6 Metabolic Network Models Au Jennifer Synthetic Microbial Metabolism Refactoring for the Production 7 of a Chemical Synthon, 2,4-Dihydroxybutyric Acid Auriol Clément Implementation of a Disassociated Fatty Acid Synthase System (FAS type II) in Saccharomyces Cerevisiae for Fatty Acid and 8 Wax Ester Production Azevedo Flávio Production of 4-Hydroxybutyric Acid By Metabolically Engineered Mannheimia Succiniciproducens and Its Conversion 9 to Gamma-Butyrolactone By Acid Treatment Bang Junho Challenges in Reverse Engineering of Industrial Fermentation 10 Strains Benjamin Kirsten R. Metabolic Engineering for Ricinoleic Acid Production in Y. 11 Lipolytica Beopoulos Athanasios Fatty Acid Overproduction in a Genetically Engineered Puryvate 12 Decarboxylase-Negative Strain of Saccharomyces Cerevisiae Bergman Alexandra Isolation, Characterization and Metabolic Engineering of a 13 Thermophilic Bacillus for Green Chemical Production Bosma Elleke F.
    [Show full text]
  • Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Dysmenorrhea
    Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Dysmenorrhea Chemical Activity Count (+)-ADLUMINE 1 (+)-ALLOMATRINE 1 (+)-ALPHA-VINIFERIN 1 (+)-BORNYL-ISOVALERATE 1 (+)-CATECHIN 4 (+)-EUDESMA-4(14),7(11)-DIENE-3-ONE 1 (+)-GALLOCATECHIN 1 (+)-HERNANDEZINE 1 (+)-ISOCORYDINE 2 (+)-PSEUDOEPHEDRINE 1 (+)-T-CADINOL 1 (-)-16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 (-)-ALPHA-BISABOLOL 3 (-)-ANABASINE 1 (-)-ARGEMONINE 1 (-)-BETONICINE 1 (-)-BORNYL-CAFFEATE 1 (-)-BORNYL-FERULATE 1 (-)-BORNYL-P-COUMARATE 1 (-)-DICENTRINE 2 (-)-EPIAFZELECHIN 1 (-)-EPICATECHIN 1 (-)-EPIGALLOCATECHIN-GALLATE 1 (1'S)-1'-ACETOXYCHAVICOL-ACETATE 1 (15:1)-CARDANOL 1 (E)-4-(3',4'-DIMETHOXYPHENYL)-BUT-3-EN-OL 1 1,7-BIS-(4-HYDROXYPHENYL)-1,4,6-HEPTATRIEN-3-ONE 1 Chemical Activity Count 1,8-CINEOLE 6 10-ACETOXY-8-HYDROXY-9-ISOBUTYLOXY-6-METHOXYTHYMOL 1 10-DEHYDROGINGERDIONE 1 10-GINGERDIONE 1 11-HYDROXY-DELTA-8-THC 1 11-HYDROXY-DELTA-9-THC 1 12,118-BINARINGIN 1 12-ACETYLDEHYDROLUCICULINE 1 13',II8-BIAPIGENIN 1 13-OXYINGENOL-ESTER 1 16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 16-EPIMETHUENINE 1 16-HYDROXYINGENOL-ESTER 1 2'-HYDROXY-FLAVONE 1 2'-O-GLYCOSYLVITEXIN 1 2-BETA,3BETA-27-TRIHYDROXYOLEAN-12-ENE-23,28-DICARBOXYLIC-ACID 1 2-METHYLBUT-3-ENE-2-OL 1 20-DEOXYINGENOL-ESTER 1 22BETA-ESCIN 1 24-METHYLENE-CYCLOARTANOL 2 3,4-DIMETHOXYTOLUENE 1 3,4-METHYLENE-DIOXYCINNAMIC-ACID-BORNYL-ESTER 2 3,4-SECOTRITERPENE-ACID-20-EPI-KOETJAPIC-ACID 1 3-ACETYLACONITINE 3 3-ACETYLNERBOWDINE 1 3-BETA-ACETOXY-20,25-EPOXYDAMMARANE-24-OL 1 3-BETA-HYDROXY-2,3-DIHYDROWITHANOLIDE-F
    [Show full text]
  • Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Epilepsy
    Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Epilepsy Chemical Activity Count (+)-ALPHA-VINIFERIN 1 (+)-BORNYL-ISOVALERATE 1 (+)-CATECHIN 3 (+)-EUDESMA-4(14),7(11)-DIENE-3-ONE 1 (+)-HERNANDEZINE 1 (+)-ISOCORYDINE 1 (+)-PSEUDOEPHEDRINE 1 (+)-SYRINGARESINOL-DI-O-BETA-D-GLUCOSIDE 1 (+)-T-CADINOL 1 (-)-16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 (-)-ALPHA-BISABOLOL 2 (-)-ANABASINE 1 (-)-APOGLAZIOVINE 1 (-)-BETONICINE 1 (-)-BORNYL-CAFFEATE 1 (-)-BORNYL-FERULATE 1 (-)-BORNYL-P-COUMARATE 1 (-)-DICENTRINE 2 (-)-EPIAFZELECHIN 1 (-)-EPICATECHIN 1 (-)-EPIGALLOCATECHIN-GALLATE 1 (1'S)-1'-ACETOXYCHAVICOL-ACETATE 1 (15:1)-CARDANOL 1 (E)-4-(3',4'-DIMETHOXYPHENYL)-BUT-3-EN-OL 1 1,7-BIS-(4-HYDROXYPHENYL)-1,4,6-HEPTATRIEN-3-ONE 1 1,8-CINEOLE 4 10-ACETOXY-8-HYDROXY-9-ISOBUTYLOXY-6-METHOXYTHYMOL 1 Chemical Activity Count 10-DEHYDROGINGERDIONE 1 10-GINGERDIONE 1 11-HYDROXY-DELTA-8-THC 1 11-HYDROXY-DELTA-9-THC 1 13',II8-BIAPIGENIN 1 13-OXYINGENOL-ESTER 1 16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 16-EPIMETHUENINE 1 16-HYDROXYINGENOL-ESTER 1 2'-O-GLYCOSYLVITEXIN 1 2-BETA,3BETA-27-TRIHYDROXYOLEAN-12-ENE-23,28-DICARBOXYLIC-ACID 1 2-METHYLBUT-3-ENE-2-OL 2 20-DEOXYINGENOL-ESTER 1 22BETA-ESCIN 1 24-METHYLENE-CYCLOARTANOL 1 3,3'-DIMETHYLELLAGIC-ACID 1 3,4-DIMETHOXYTOLUENE 1 3,4-METHYLENE-DIOXYCINNAMIC-ACID-BORNYL-ESTER 2 3,4-SECOTRITERPENE-ACID-20-EPI-KOETJAPIC-ACID 1 3-ACETYLACONITINE 1 3-ACETYLNERBOWDINE 1 3-BETA-HYDROXY-2,3-DIHYDROWITHANOLIDE-F 1 3-HYDROXY-FLAVONE 1 3-N-BUTYL-PHTHALIDE 3 3-O-ACETYLOLEANOLIC-ACID 1 3-OXO-11-ALPHA-HYDROXYOLEAN-12-ENE-30-OIC-ACID
    [Show full text]
  • Effects of Oleic and Ricinoleic Acids on Net Jejunal Water and Electrolyte Movement
    Effects of Oleic and Ricinoleic Acids on Net Jejunal Water and Electrolyte Movement PERFUSION STUDIES IN MAN HELMUT V. AMMON, PAUL J. THOMAS, and SIDNEY F. PHILLIPS From the Gastroenterology Unit, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55901 ABSTRA CT To examine the effects of oleic acid by bacterial hydration of unsaturated dietary fatty acids and ricinoleic acid on jejunal absorption, steady-state (2), are chemically similar to a known cathartic, ricino- jejunal perfusions were performed in healthy volunteers. leic acid. This hypothesis of the action of hydroxy fatty Taurocholate, used to solubilize the fatty acids, did not acids is supported by the results of other investigations: influence absorption. Both fatty acids (concentration, the study of animals with an experimental "blind loop 10 mM) reversed electrolyte and water net movement; syndrome" (3), perfusion of the intestine with fatty that is, they induced fluid secretion; this effect was acid solutions (4), and analysis of steatorrheal stools rapidly reversible. Ricinoleic acid (the active principle in man (5). Specifically, hydroxy fatty acids provoke of castor oil) was the more potent, producing fluid se- water secretion in the rat colon (4) and impair net cretion when perfused at concentrations at which oleic fluid movement in the human colon (6). In the canine acid was without effect. However, ricinoleic acid was ileum, however, water absorption has been blocked not absorbed more slowly than was oleic acid, and hence only by 10-hydroxystearic acid and ricinoleic acid (the was associated with higher intraluminal concentrations. active principle of castor oil) but also by oleic acid (7).
    [Show full text]
  • Tepzz Z89z ¥B T
    (19) TZZ ZZ_¥_T (11) EP 2 089 013 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: A61K 31/167 (2006.01) A61K 31/192 (2006.01) 27.09.2017 Bulletin 2017/39 A61K 45/06 (2006.01) A61P 29/00 (2006.01) (21) Application number: 07854106.7 (86) International application number: PCT/US2007/081589 (22) Date of filing: 17.10.2007 (87) International publication number: WO 2008/051759 (02.05.2008 Gazette 2008/18) (54) COMBINATION OF ACETAMINOPHEN WITH IBUPROFEN FOR THE TREAMENT OF PAIN KOMBINATION VON ACETAMINOPHEN MIT IBUPROFEN ZUR BEHANDLUNG VON SCHMERZEN. COMBINAISON DE ACÉTAMINOPHÈNE ET IBUPROFÈNE POUR LE TRAITEMENT DE DOULEUR (84) Designated Contracting States: (74) Representative: Kirsch, Susan Edith et al AT BE BG CH CY CZ DE DK EE ES FI FR GB GR Carpmaels & Ransford LLP HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE One Southampton Row SI SK TR London WC1B 5HA (GB) (30) Priority: 20.10.2006 US 853509 P (56) References cited: EP-A- 0 012 621 EP-A- 0 109 281 (43) Date of publication of application: WO-A-2006/004449 US-A- 5 409 709 19.08.2009 Bulletin 2009/34 • MIRANDA ET AL: "Synergism between (73) Proprietor: Johnson & Johnson Consumer Inc. paracetamol and nonsteroidal anti-inflammatory Skillman, NJ 08558 (US) drugs in experimental acute pain" PAIN, ELSEVIER SCIENCE PUBLISHERS, (72) Inventors: AMSTERDAM, NL, vol. 121, no. 1-2, March 2006 • SWANN, Jim (2006-03), pages 22-28, XP005330893 ISSN: Waterloo, ON N2L 5Y8 (CA) 0304-3959 • CUMMINS, Peter Guelph, ON N1L 1B4 (CA) Note: Within nine months of the publication of the mention of the grant of the European patent in the European Patent Bulletin, any person may give notice to the European Patent Office of opposition to that patent, in accordance with the Implementing Regulations.
    [Show full text]
  • Assessment Report on Ricinus Communis L., Oleum Draft
    7 July 2015 EMA/HMPC/572973/2014 Committee on Herbal Medicinal Products (HMPC) Assessment report on Ricinus communis L., oleum Draft Based on Article 10a of Directive 2001/83/EC as amended (well-established use) Herbal substance(s) (binomial scientific name of the plant, including plant part) Ricinus communis L., oleum (castor oil) Herbal preparation Fatty oil obtained from seeds of Ricinus communis L. by cold expression Pharmaceutical forms Herbal preparation in liquid or solid dosage forms for oral use Rapporteur C. Purdel Peer-reviewer B. Kroes Note: This draft assessment report is published to support the public consultation of the draft European Union herbal monograph on Ricinus communis L., oleum. It is a working document, not yet edited, and shall be further developed after the release for consultation of the monograph. Interested parties are welcome to submit comments to the HMPC secretariat, which will be taken into consideration but no ‘overview of comments received during the public consultation’ will be prepared on comments that will be received on this assessment report. The publication of this draft assessment report has been agreed to facilitate the understanding by Interested Parties of the assessment that has been carried out so far and led to the preparation of the draft monograph. 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/ contact An agency of the European Union © European Medicines Agency, 2015. Reproduction is authorised provided the source is acknowledged. Table of contents Table of contents ..................................................................................................................
    [Show full text]
  • Evaluation of the Anti-Diarrheal Activity of the Leaf Extract of Croton Macrostachyus Hocsht. Ex Del.(Euphorbiaceae) in Mice Model
    Degu et al. BMC Complementary and Alternative Medicine (2016) 16:379 DOI 10.1186/s12906-016-1357-9 RESEARCH ARTICLE Open Access Evaluation of the anti-diarrheal activity of the leaf extract of Croton macrostachyus Hocsht. ex Del. (Euphorbiaceae) in mice model Amsalu Degu1* , Ephrem Engidawork2 and Workineh Shibeshi2 Abstract Background: Traditional healers in Ethiopia use a wide range of medicinal plants with antidiarrheal properties. Among these, Croton macrostachyus is one such plant claimed to have an antidiarrheal activity in Ethiopian folklore medicine. Previous studies showed that the crude extract is endowed with the claimed property. The present study was undertaken to further the claim by screening different fractions for the said activity so that it could serve as a basis for subsequent studies. Methods: The fractions were obtained by successive extraction in soxhlet apparatus with solvents of different polarity (chloroform & methanol) followed by cold maceration of the deposit of the methanol fraction with distilled water. The antidiarrheal activity was evaluated using castor oil induced diarrheal model, charcoal meal test and anti-enteropooling test in mice. The test groups received various doses (300, 400, 500 mg/kg and an additional dose of 1000 mg/kg for the aqueous fraction) of the fractions, whereas positive controls received either Loperamide (3 mg/kg) or Atropine (5 mg/kg) and negative controls received vehicle (10 ml/kg). Results: In the castor oil induced model, the chloroform (at all test doses) and methanol (at 400 & 500 mg/kg) fractions significantly delayed diarrheal onset, decreased stool frequency and weight of feces. The aqueous fraction was however devoid of significant effect at all the tested doses.
    [Show full text]
  • Faecal Free Fatty Acids in Tropical Sprue and Their Inhibition of Atpases
    Gut: first published as 10.1136/gut.24.4.300 on 1 April 1983. Downloaded from Gut, 1983. 24, 30W-305 Faecal free fatty acids in tropical sprue and their possible role in the production of diarrhoea by inhibition of ATPases C TIRUPPATHI, K A BALASUBRAMANIAN, P G HILL, AND V I MATHAN From the Wellcome Research Unit, Christian Medical College Hospital, Vellore, India SUMMARY Faecal excretion of fatty acids is increased in patients with tropical sprue because of unabsorbed dietary fatty acids. The excretion of fatty acids correlates well with faecal wet weight. In vitro unsaturated fatty acids inhibited Na K-ATPase and Mg-ATPase isolated from basolateral membranes of enterocytes and colonocytes. These findings are a possible explanation for the observed abnormalities in water and electrolyte absorption by the colon in patients with tropical sprue and steatorrhoea. Colonic water and electrolyte absorption is defective ward diet containing 50 g fat per day and the analysis in patients with tropical sprue.' Faecal free fatty was done after at least one week on this diet. The acids could play a role in the pathogenesis of this dietary fat was mnainly groundnut oil and analysis of functional defect of the colon in patients with a typical 24 hour diet showed that palmitic (16:0), tropical sprue and steatorrhoea. The precise role of oleic (18: 1). and linoleic (18:2) acids were the major http://gut.bmj.com/ fatty acids in the genesis of diarrhoea associated fatty acids (Fig. 1). with steatorrhoea is not clear' but it has been Faeces were passed into polyethylene containers suggested that hydroxv fatty acids could produce a and kept immediately by the patients in a freezer secretory diarrhoea.3 This paper reports the (-200C).
    [Show full text]
  • Diacylglycerol Acyltransferase Activity and Triacylglycerol Synthesis in Germinating Castor Seed Cotyledons Xiaohua He, Grace Q
    Diacylglycerol Acyltransferase Activity and Triacylglycerol Synthesis in Germinating Castor Seed Cotyledons Xiaohua He, Grace Q. Chen, Jiann-Tsyh Lin, and Thomas A. McKeon* Western Regional Research Center, USDA, Albany, California 94710 ABSTRACT: The central importance of storage lipid break- erolipid synthesis were present and active in soybean cotyle- down in providing carbon and energy during seed germination dons during seed germination (4). The synthesis of TAG has has been demonstrated by isolating the genes encoding the en- also been shown to occur during seed germination of some zymes involved in FA β-oxidation. In contrast, little is known plants, such as the pea (5), cucumber (6), and soybean (7). about the ability of germinating seeds to synthesize TAG. We These observations suggest the presence of DAG acyltrans- report that castor cotyledons are capable of TAG synthesis. The ferase (DGAT) in germinating seeds. Recently, we identified a rate of incorporation of ricinoleic acid into TAG reached a peak cDNA encoding DGAT from castor seed (RcDGAT) based on at 7 d after imbibition (DAI) (1.14 nmol/h/mg) and decreased rapidly thereafter, but was sustained at 20 DAI in cotyledons its homology to other plant-type DGAT1 cDNA (8) and inves- and true leaves. The castor DAG acyltransferase (RcDGAT) tigated the expression of the RcDGAT gene and DGAT activ- mRNA and protein were expressed throughout seed germina- ity in developing seeds (9). In this study we extend our exami- tion at levels considerably enhanced from that in the dormant nation of the RcDGAT gene and protein to cotyledons of ger- seed, thus indicating new expression.
    [Show full text]